home / stock / gnca / gnca news

GNCA News and Press, Genocea Biosciences Inc. From 10/24/19

Stock Information
Company Name: Genocea Biosciences Inc.
Stock Symbol: GNCA
Market: NASDAQ
Menu
GNCA GNCA Quote GNCA Short GNCA News GNCA Articles GNCA Message Board
Get GNCA Alerts

News, Short Squeeze, Breakout and More Instantly...
GNCA - Genocea Biosciences EPS beats by $0.18

Genocea Biosciences (NASDAQ: GNCA ): Q3 GAAP EPS of -$0.28 beats by $0.18 . More news on: Genocea Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

GNCA - Genocea to Host Third Quarter 2019 Corporate Update Conference Call & Webcast

CAMBRIDGE, Mass., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, will host its third quarter 2019 financial results and corporate update conference call and live audio webcast...

GNCA - Genocea Biosciences (GNCA) Investor Presentation - Slideshow

The following slide deck was published by Genocea Biosciences, Inc. in conjunction with this Read more ...

GNCA - Genocea Announces Poster Presentation at The European Society for Medical Oncology (ESMO) Congress 2019 in Barcelona and Presentation at an Upcoming Investor Conference

Additional p ositive GEN-009 c linical i mmunogenicity d ata d riven by ATLAS™ to be p resented at ESMO Company to present at the Cantor Fitzgerald 2019 Global Healthcare Conference CAMBRIDGE, Mass., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Genocea Bio...
GNCA - Genocea to Present at September Healthcare Conferences

CAMBRIDGE, Mass., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that Chip Clark, president and chief executive officer, will present at two leading healthcare confer...

GNCA - Genocea Biosciences, Inc. (GNCA) CEO William Clark on Q2 2019 Results - Earnings Call Transcript

Genocea Biosciences, Inc. (GNCA) Q2 2019 Earnings Conference Call July 25, 2019, 08:30 ET Company Participants Daniel Ferry - LifeSci Advisors William Clark - President, CEO & Director Diantha Duvall - CFO Thomas Davis - Chief Medical Officer Conference Call Participants...

GNCA - Genocea Biosciences EPS beats by $0.24

Genocea Biosciences (NASDAQ: GNCA ): Q2 GAAP EPS of -$0.42 beats by $0.24 . More news on: Genocea Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

GNCA - Genocea Provides Corporate Update, Including Second-Quarter 2019 Financial Results

Initiated Part B of Phase 1/2a clinical trial of neoantigen vaccine candidate GEN-009; Plans to present additional GEN-009 immunogenicity data at ESMO 2019 Conference call today at 8:30 am ET CAMBRIDGE, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (...

GNCA - Genocea to Host Quarterly Corporate Update Conference Call & Webcast on July 25th at 8:30 am ET

CAMBRIDGE, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, will host its second-quarter 2019 financial results and corporate update conference call and live audio webcast on Th...

GNCA - OASM, BLCM among premarket gainers

Oasmia Pharmaceutical AB (NASDAQ: OASM ) +22% . More news on: Oasmia Pharmaceutical AB (publ), Sangamo Therapeutics, Inc., Aytu BioScience, Inc., Stocks on the move, Read more ...

Previous 10 Next 10